Involvement of 5-hydroxytryptamine 5-HT3 serotonergic receptors in the acquisition and reinstatement of the conditioned place preference induced by MDMA

European Journal of Pharmacology

Volumn 714, Issue 1-3, 2013, Pages 132-141

  Roger Sánchez, Concepción ^a   Rodríguez Arias, Marta ^a   Miñarro, Jose ^a   Aguilar, Maria A ^a  

^a UNIVERSITY OF VALENCIA   (Spain)

Author keywords

Adolescence (Mouse); Conditioned place preference; MDMA

Indexed keywords

3,4 METHYLENEDIOXYMETHAMPHETAMINE; 5 HYDROXYINDOLEACETIC ACID; BEMESETRON; DIHYDROXYPHENYLACETIC ACID; DOPAMINE; SEROTONIN; SEROTONIN 3 RECEPTOR;

ADOLESCENT; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN CORTEX; CORPUS STRIATUM; LOW DRUG DOSE; MALE; MOTIVATION; MOUSE; NONHUMAN; PLACE PREFERENCE; PRIORITY JOURNAL; PROTEIN FUNCTION; REWARD;

(MOUSE); 5-HYDROXYTRYPTAMINE 5-HT(3) RECEPTOR; ADOLESCENCE; CONDITIONED PLACE PREFERENCE; MDMA;

ANIMALS; BIOGENIC AMINES; CONDITIONING (PSYCHOLOGY); MALE; MICE; N-METHYL-3,4-METHYLENEDIOXYAMPHETAMINE; RECEPTORS, SEROTONIN, 5-HT3; REWARD; SPATIAL BEHAVIOR;

EID: 84880184575     PISSN: 00142999     EISSN: 18790712     Source Type: Journal    
DOI: 10.1016/j.ejphar.2013.06.005     Document Type: Article

References (39)

1. Acquas, E., Carboni, E., Garau, L., Di Chiara, G., 1990. Blockade of acquisition of drug-conditioned place aversion by 5HT3 antagonists. Psychopharmacology 4, 459-463. (Pubitemid 20102352)
2. Aguilar, M.A., Rodríguez-Arias, M., Minarro, J., 2009. Neurobiological mechanisms of the reinstatement of drug-conditioned place preference. Brain Res. Rev. 2, 253-277.
3. Beninger, R.J., 1989. Dissociating the effects of altered dopaminergic function on performance and learning. Brain Res. Bull. 4-5, 365-371. (Pubitemid 20008442)
4. 3 receptor antagonist, blocks MDMA's ability to establish a conditioned place preference. Pharmacol. Biochem. Behav. 2, 509-512.
5. Bilsky, E.J., Montegut, M.J., Nichols, M.L, Reid, L.D., 1998. CGS 10746B, a novel dopamine release inhibitor, blocks the establishment of cocaine and MDMA conditioned place preferences. Pharmacol. Biochem. Behav. 1, 215-220. (Pubitemid 28053701)
6. Braida, D., Iosuè, S., Pegorini, S., Sala, M., 2005. 3,4-Methylenedioxymethamphetamine-induced conditioned place preference (CPP) is mediated by endocannabinoid system Pharmacol. Res. 2, 177-182. (Pubitemid 40040550)
7. Cadoni, C, Solinas, M., Pisanu, A., Zernig, G., Acquas, E., Di Chiara, G., 2005. Effect of 3,4-methylendioxymethamphetamine (MDMA, ecstasy) on dopamine transmission in the nucleus accumbens shell and core. Brain Res. 1-2, 143-148. (Pubitemid 41224238)
8. 3 receptor antagonists do not modify cocaine place conditioning or the rise in extracellular dopamine in the nucleus accumbens of rats. Pharmacol. Biochem. Behav. 55, 33-37. (Pubitemid 26285690)
9. Colussi-Mas, J., Wise, R.J., Howard, A., Schenk, S., 2010. Drug seeking in response to a priming injection of MDMA in rats: relationship to initial sensitivity to self-administered MDMA and dorsal striatal dopamine. Int. J. Neuropsychopharma-col. 10, 1315-1327.
10. Cottler, L.B., Womack, S.B., Compton, W.M., Ben Abdallah, A., 2001. Ecstasy abuse and dependence among adolescents and young adults: applicability and reliability of DSM-IV criteria. Hum. Psychopharmacol. Clin. Exp. 8, 599-606. (Pubitemid 34036940)
11. Davidson, C., Gopalan, R., Ahn, C., Chen, Q., Mannelli, P., Patkar, A.A., Weese, G.D., Lee, T.H., Ellinwood, E.H., 2007. Reduction in methamphetamine induced sensitization and reinstatement after combined pergolide plus ondansetron treatment during withdrawal. Eur. J. Pharmacol. 1-3, 113-118. (Pubitemid 46782781)
12. Daza-Losada, M., Ribeiro Do Couto, B., Manzanedo, C., Aguilar, M.A., Rodríguez-Arias, M., Miñarro, J., 2007. Rewarding effects and reinstatement of MDMA-induced CPP in adolescent mice. Neuropsychopharmacology 8, 1750-1759. (Pubitemid 47076389)
13. Daza-Losada, M., Rodríguez-Arias, M., Aguilar, M.A., Miñarro, J., 2009. Acquisition and reinstatement of MDMA-induced conditioned place preference in mice pre-treated with MDMA or cocaine during adolescence. Addict. Biol. 4, 447-456.
14. Degenhardt, L., Bruno, R., Topp, L., 2010. Is ecstasy a drug of dependence? Drug Alcohol Depend. 1, 1-10.
15. 2B receptors in the reinforcing effects of MDMA in mice. PLoS One 11, e7952.
16. Dremencov, E., Weizmann, Y., Kinor, N., Gispan-Herman, I., Yadid, G., 2006. Modulation of dopamine transmission by 5HT2C and 5HT3 receptors: a role in the antidepressant response. Curr. Drug Targets 2, 165-175.
17. 3 receptors in drug abuse and as a target for pharmacotherapy. CNS Neurol. Disord. Drug Targets 7, 454-467.
18. Fantegrossi, W.E., Ullrich, T., Rice, K.C., Woods, J.H., Winger, G., 2002. 3,4-Methy-lenedioxymethamphetamine (MDMA, ecstasy) and its stereoisomers as rein-forcers in rhesus monkeys: serotonergic involvement. Psychopharmacology 4, 356-364. (Pubitemid 34595786)
19. Fozard, J.R., 1984. MDL 72222: a potent and highly selective antagonist at neuronal 5-hydroxytryptamine receptors. Naunyn-Schmiedebergs Arch. Pharmacol. 1, 36-44. (Pubitemid 14124680)
20. Gudelsky, G.A., Yamamoto, B.K., 2008. Actions of 3,4-methylene- dioxymethamphe-tamine (MDMA) on cerebral dopaminergic, serotonergic and cholinergic neurons. Pharmacol. Biochem. Behav. 2, 198-207. (Pubitemid 351787346)
21. Heffner, T.G., Hartman, J.A., Seiden, L.S., 1980. A rapid method for the regional dissection of the rat brain. Pharmacol. Biochem. Behav. 3, 453-456. (Pubitemid 10008987)
22. Hubner, C.B., Bird, M., Rassnick, S., Kornetsky, C., 1988. The threshold lowering effects of MDMA (ecstasy) on brain-stimulation reward. Psychopharmacology 1, 49-51.
23. Kalivas, P.W., O'Brien, C., 2008. Drug addiction as a pathology of staged neuroplas-ticity. Neuropsychopharmacology 1, 166-180. (Pubitemid 350191316)
24. 3 receptor antagonist MDL 72222 attenuates cocaine- and mazindol-, but not methylphenidate-induced neurochemical and behavioral effects in the rat. Psychopharmacology 4, 341-350. (Pubitemid 34143358)
25. Kehr, J., Ichinose, F., Yoshitake, S., Goiny, M., Sievertsson, T., Nyberg, F., Yoshitake, T., 2011. Mephedrone, compared with MDMA (ecstasy) and amphetamine, rapidly increases both dopamine and 5-HT levels in nucleus accumbens of awake rats. Br. J. Pharmacol. 164, 1949-1958.
26. 3 receptor antagonists on stress-induced reinstatement of alcohol seeking in rats. Psychopharmacology 1, 82-92. (Pubitemid 43668313)
27. Leung, K.S., Ben Abdallah, A., Copeland, J., Cottler, L.B., 2010. Modifiable risk factors of ecstasy use: risk perception, current dependence, perceived control, and depression. Addict. Behav. 3, 201-208.
28. Manzanedo, C., Rodríguez-Arias, M., Daza-Losada, M., Maldonado, C., Aguilar, M.A., Miñarro, J., 2010. Effect of the CB1 cannabinoid agonist WIN 55212-2 on the acquisition and reinstatement of MDMA-induced conditioned place preference in mice. Behav. Brain Funct. 6, 19.
29. 2A receptors in MDMA reinforcement and cue-induced reinstatement of MDMA-seeking behaviour. Int. J. Neuropsychopharmacol. 14, 927-940.
30. Psychoactive Drug Screening Program (PDSP) Ki Database. Available at: (https://app.collaborativedrug.com/portal/searches/new) (accessed 24.03.12).
31. Ribeiro Do Couto, B., Rodríguez-Arias, M., Fuentes, S., Gagliano, H., Armario, A., Miñarro, J., Aguilar, M.A., 2011. Adolescent pre-exposure to ethanol or MDMA prolongs the conditioned rewarding effects of MDMA. Physiol. Behav. 5, 585-593.
32. Ribeiro Do Couto, B., Daza-Losada, M., Rodríguez-Arias, M., Nadal, R., Guerri, C., Summavielle, T., Miñarro, J., Aguilar, M.A., 2012. Adolescent pre-exposure to ethanol and 3,4-methylenedioxymethylamphetamine (MDMA) increases conditioned rewarding effects of MDMA and drug-induced reinstatement. Addict. Biol. 17, 588-600.
33. Rodríguez-Arias, M., Manzanedo, C., Roger-Sánchez, C., Ribeiro Do Couto, B., Aguilar, M.A., Miñarro, J., 2010. Effect of adolescent exposure to WIN 55212-2 on the acquisition and reinstatement of MDMA-induced conditioned place preference. Prog. Neuropsychopharmacol. Biol. Psychiatry 1, 166-171.
34. Rudnick, G., Wall, S.C., 1992. The molecular mechanism of ecstasy [3,4-methylene-dioxy-methamphetamine (MDMA)]: serotonin transporters are targets for MDMA-induced serotonin release. Proc. Natl. Acad. Sci. USA 5, 1817-1821.
35. Schenk, S., 2009. MDMA self-administration in laboratory animals: a summary of the literature and proposal for future research. Neuropsychobiology 3-4, 130-136.
36. Schmidt, C.J., Levin, J.A., Lovenberg, W., 1987. In vitro and in vivo neurochemical effects of methylenedioxymethamphetamine on striatal monoaminergic systems in the rat brain. Biochem. Pharmacol. 5, 747-755. (Pubitemid 17026095)
37. Trigo, J.M., Renoir, T., Lanfumey, L., Hamon, M., Lesch, K.P., Robledo, P., Maldonado, R., 2007. 3,4-methylenedioxymethamphetamine self-administration is abolished in serotonin transporter knockout mice. Biol. Psychiatry 6, 669-679. (Pubitemid 47314373)
38. Tzschentke, T.M., 2007. Measuring reward with the conditioned place preference (CPP) paradigm: update of the last decade. Addict. Biol. 3-4, 227-462. (Pubitemid 47196347)
39. Vidal-Infer, A., Roger-Sánchez, C., Daza-Losada, M., Aguilar, M., Miñarro, J., Rodríguez-Arias, M., 2012. Role of the dopaminergic system in the acquisition, expression and reinstatement of MDMA-induced conditioned place preference in adolescent mice. PLoS one 7 (8), e43107.